AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Washington Highlights > February 14, 2003

AAMC Comments on Select Agents Rule

February 14, 2003 - Federal regulations governing possession and use of biological "select agents" went into effect Feb. 7. The regulations, in the form of an interim final rule published by the Department of Health and Human Services on Dec. 13, 2002, and a companion rule published by the U.S. Department of Agriculture, establish requirements for the safety and security of research involving specified pathogens and toxins, pursuant to anti-terrorism legislation signed by President Bush last June. The Centers for Disease Control and Prevention (CDC), which led the DHHS effort developing the rule, invited public comments for a two-month period ending Feb. 11.

In its comment letter, the AAMC commended the CDC for adopting a performance-based approach for institutions complying with the rule and argued for a more consistent application of this approach in the rule's security provisions. In particular, the AAMC was troubled that the interim final rule does not sufficiently specify the procedures and process for obtaining a required "security risk assessment" from the U.S. Attorney General, although the first of a series of deadlines for applying for these assessments ends March 12, 2003. The AAMC's comments endorsed a comprehensive and detailed set of recommendations developed by the Howard Hughes Medical Institute (HHMI) in collaboration with safety officers from leading academic institutions. The AAMC and HHMI urged the government to consolidate the CDC and USDA offices that process select agent registrations.

Researchers should be reminded that the federal government has created a temporary repository for select agents that might otherwise be destroyed by institutions or investigators discontinuing their research on these substances. Interested persons should contact the CDC's Bioterrorism Preparedness and Response Program.

Information:
Stephen Heinig, Senior Research Fellow
AAMC Biomedical Health Sciences Research
sheinig@aamc.org
(202) 828-0488

e-mail icon Get Washington Highlights in your Inbox!

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement